121 related articles for article (PubMed ID: 28092772)
21. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
Wu J; Xu X; Lee EJ; Shull AY; Pei L; Awan F; Wang X; Choi JH; Deng L; Xin HB; Zhong W; Liang J; Miao Y; Wu Y; Fan L; Li J; Xu W; Shi H
Oncotarget; 2016 Jun; 7(26):40558-40570. PubMed ID: 27302925
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
23. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
[TBL] [Abstract][Full Text] [Related]
24. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus.
Frenzel LP; Claus R; Plume N; Schwamb J; Konermann C; Pallasch CP; Claasen J; Brinker R; Wollnik B; Plass C; Wendtner CM
Int J Cancer; 2011 May; 128(10):2495-500. PubMed ID: 20669229
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
26. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
28. CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation.
Nakaima Y; Watanabe K; Koyama T; Miura O; Fukuda T
PLoS One; 2013; 8(5):e64425. PubMed ID: 23696891
[TBL] [Abstract][Full Text] [Related]
29. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.
Billot K; Soeur J; Chereau F; Arrouss I; Merle-Béral H; Huang ME; Mazier D; Baud V; Rebollo A
Blood; 2011 Feb; 117(6):1917-27. PubMed ID: 21139082
[TBL] [Abstract][Full Text] [Related]
30. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A
Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
[TBL] [Abstract][Full Text] [Related]
31. In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors.
Fonte E; Apollonio B; Scarfò L; Ranghetti P; Fazi C; Ghia P; Caligaris-Cappio F; Muzio M
Clin Cancer Res; 2013 Jan; 19(2):367-79. PubMed ID: 23224401
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
[TBL] [Abstract][Full Text] [Related]
33. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
34. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
35. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
36. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
37. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K
Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497
[TBL] [Abstract][Full Text] [Related]
38. Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.
Maffei R; Fiorcari S; Vaisitti T; Martinelli S; Benatti S; Debbia G; Rossi D; Zucchini P; Potenza L; Luppi M; Gaidano G; Deaglio S; Marasca R
Oncotarget; 2017 Oct; 8(52):90013-90027. PubMed ID: 29163807
[TBL] [Abstract][Full Text] [Related]
39. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
